Our @anzuptrials.bsky.social #GDISCO (ANZUP 2403) #BladderCancer study (Gemcitabine Docetaxel Intra-vesical Synchronous CO-administration) has reached full recruitment! Well done to all involved in this important #BladderCancer study #ProfDickonHayne #CynthiaHawkes #SMHS @profiand.bsky.social

Congrats to our @anzuptrials.bsky.social #GDISCO (ANZUP 2403) TiP poster presented by #KevinKeane @ascocancer.bsky.social #GU25. Well done to all involved in this important #BladderCancer study #ProfDickonHayne #CancerAustralia @profiand.bsky.social

No sooner had our @anzuptrials.bsky.social #GDISCO (ANZUP 2403) study open at Fiona Stanley Hospital in Perth, the first participant has been recruited! Well done to all involved in this important #BladderCancer study #SMHS #CancerAustralia @profiand.bsky.social

Our @anzuptrials.bsky.social #GDISCO (ANZUP 2403) #BladderCancer study (Gemcitabine Docetaxel Intra-vesical Synchronous CO-administration) is officially now open at Fiona Stanley Hospital in Perth #SMHS #CancerAustralia @profiand.bsky.social